MedTrace Logo

From PSA to Stockholm3: Study Part 1

NCT03381105 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 13431

Last updated 2023-04-24

No results posted yet for this study

Summary

This part of the project aims to analyze the effectiveness of the Stockholm3 test in regular clinical practice, both in general practice and in the specialist health care, as a tool for detecting patients who need further diagnostics for prostate cancer.

Conditions

Interventions

DIAGNOSTIC_TEST

PSA and Stockholm3

The new Stockholm3 test and traditional PSA test

Sponsors & Collaborators

Principal Investigators

  • Svein Kjosavik, MS PhD · Helse Stavanger HF

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-09-01
Primary Completion
2021-12-31
Completion
2030-12-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03381105 on ClinicalTrials.gov